United States

Back to map

Showing 71-80 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
NKG2D Signaling as a Critical Modulator of Autoreactive CD8⁺ T Cell Differentiation and β Cell Destruction in Type 1 Diabetes University of Kansas Medical Center Research Institute, Inc. Ambika Dudhate Cures 01-March-2026 to 28-February-2029 $274,010.00
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2 University of Florida Todd Brusko Cures 01-September-2024 to 31-August-2026 $500,000.00
Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression University of Florida Sarah Kim Cures 01-June-2022 to 31-May-2026 $750,000.00
Network for Pancreatic Organ Donors – nPOD University of Florida Mark Atkinson Cures 01-October-2023 to 30-September-2026 $8,100,000.00
Orthogonal engineering to suppress autoreactive T cell activation in T1D cell therapy University of Florida Jessie Barra Cures 01-March-2024 to 28-February-2027 $190,000.00
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D University of Florida Graciela Lorca Cures 01-September-2019 to 31-August-2026 $355,941.78
Tolerance signals from human pregnancy for beta cell replacement therapy University of Florida Edward Phelps Cures 01-December-2023 to 30-November-2025 $600,000.00
Prohormone convertase activity in human T1D pancreas tissue slices University of Florida Denise Drotar Cures 01-March-2025 to 29-February-2028 $264,895.00
Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort University of Florida Angelica Ahrens Cures 01-April-2026 to 31-March-2027 $199,235.28
Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation University of Florida Allison Bayer Cures 01-September-2023 to 31-March-2026 $510,297.39